The latest positive readout comes from the APPLY-PNH study, which pitted iptacopan against AstraZeneca/Alexion's anti-C5 antibodies Soliris (eculizumab) and Ultomiris (ravulizumab) in adults with ...

Apellis Pharma and partner Sobi have won EU approval for their paroxysmal nocturnal haemoglobinuria (PNH) drug pegcetacoplan in Europe, with a more restricted label than in the US. The European ...

Please provide your email address to receive an email when new articles are posted on . AF ablation with a novel contact force-sensing pulsed field catheter was safe and acutely effective.

Soliris (eculizumab) was first approved for paroxysmal nocturnal hemoglobinuria (PNH) in 2007 under Alexion, which later became AstraZeneca’s rare disease unit after its $39 billion buyout in 2020.

Ref. No: 25/01131/PNH | Validated: Tue 25 Mar 2025 | Status: Decided | Decision: Prior Approval Not Required All 17 High House Avenue, Bradford, West Yorkshire BD2 4ER. Single storey rear ...

An environmental preservation group wants to keep the park dark to support the birds and the bees. Such a designation would recognize the importance of maintaining dark skies for the variety of ...

We asked readers to channel their inner Carolyn Hax and answer this question. Some of the best responses are below. Dear Carolyn: My partner and I have completely different schedules. We both work ...

Alexion brought Soliris to market in 2007 to treat a rare and life-threatening blood disease known as paroxysmal nocturnal hemoglobinuria, and has since maintained exclusivity over the drug.

There’s no such thing as a run-of-the-mill project for Winston Yeh, the talented bike-building mastermind behind Rough Crafts. He operates out of Taiwan and is revered for his customization ...